Andrew Hantel and Lauren Merz
Nov 20, 2025, 14:05
Andrew Hantel and Lauren Merz Had an Important Conversation About Appropriate Care
American Society of Hematology shared a post on LinkedIn:
“The Duffy-null phenotype is common among individuals of African, Middle Eastern, and North African ancestry, yet often misunderstood — leading to unnecessary procedures, inappropriate dose modifications, and exclusion from potentially life-saving therapies.
Join experts Drs. Andrew Hantel and Lauren Merz for an important conversation about appropriate care. Learn how Duffy-null affects absolute neutrophil counts (ANCs), clinical trial eligibility, and treatment decisions, including:
- How standard ANC cutoffs can disadvantage patients
- Implications for chemotherapy, immunosuppressive drugs, and clozapine
- The intersection of Duffy-null with recent updates to CTC AE grading
Listen now here.”
Read more here.
Stay informed with Hemostasis Today.
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases
-
Feb 24, 2026, 15:30Aswin K Mohan: Practical Tips for Preparing Before, During, and After Blood Donation
-
Feb 24, 2026, 15:24Stéphanie Forté: The Hidden Burden of Stroke in Adults Living with Sickle Cell Disease
-
Feb 24, 2026, 15:13Tagreed Alkaltham: Equity in Emergency Care Through a Blood Bank Lens
-
Feb 24, 2026, 14:57Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?